“The clinical efficacy of integrating dolutegravir into the conventional therapeutic regimen for HIV management” (2024) International Journal of Pharmaceutical Sciences and Drug Research, 16(6), pp. 940–948. doi:10.25004/IJPSDR.2024.160603.